Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score.

Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score. PLoS One. 2016; 11(2):e0147237.

View in: PubMed

subject areas

Cost-Benefit Analysis
Elasticity Imaging Techniques
Humans
Liver
Liver Cirrhosis
Middle Aged
Non-alcoholic Fatty Liver Disease
Physicians, Primary Care
Referral and Consultation
Risk Assessment

authors with profiles

Neil Sengupta